Premium
Surgical approaches for infratemporal fossa tumor resection: Fifteen years' experience of a single center
Author(s) -
Yafit Daniel,
Duek Irit,
AbuGhanem Sara,
Ungar Omer J.,
Wengier Anat,
MosheLevyn Helena,
YankoArzi Ravit,
Zaretski Arik,
Margalit Nevo,
Abergel Avraham,
Muhanidal,
Fliss Dan M.
Publication year - 2019
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.25906
Subject(s) - infratemporal fossa , medicine , surgery , malignancy , single center , radiation therapy , adjuvant therapy , sarcoma , radiology , chemotherapy , skull , pathology
Background The aims of this study were to report our center's experience with infratemporal fossa (ITF) tumors, to review the treatment modalities and outcomes. Methods Data of patients that underwent resection of ITF tumors in a single tertiary referral medical center were collected and analyzed. Results Sixty‐three patients were included. Sarcoma was the most common pathology (18; 29%). The most common surgical approach was the preauricular‐orbitozygomatic approach (24; 38%), followed by endoscopic, craniofacial resection, and combined approaches. Forty‐seven patients (75%) required reconstruction, 23 (49%) involving free tissue transfer. Thirty‐five patients (76%) with malignant lesions required adjuvant therapy consisting of radiotherapy, chemotherapy, or both. Thirty‐three patients suffered from complications related to surgery or adjuvant therapy. The three‐ and five‐years survival rates for malignancy were 82% and 66%, respectively. Conclusion Complete surgical resection of ITF involving tumors is feasible, providing good long‐term survival. Multidisciplinary approach is the key for success.